Arbovirus

Grifols Procleix ArboPlex Assay® Receives CE Mark, the First and Only 4-in-1 NAT for Arbovirus Screening

Retrieved on: 
Thursday, April 4, 2024
Certification, Plasma, CE, GRFS, Risk, Arbovirus, Climate, RNA, GRF, Fever Dream, IVDR, Chikungunya, Death, Dengue virus, MCE, Blood bank, NAT, Vertically transmitted infection, Medical device

These are the four most significant arboviruses of concern, all spread through mosquito vectors.

Key Points: 
  • These are the four most significant arboviruses of concern, all spread through mosquito vectors.
  • With the dengue virus alone, there were more than 5 million cases and 5,000 deaths reported globally in 2023.1
    Further strengthening the Grifols Procleix portfolio for blood donor screening, the Procleix ArboPlex Assay uses plasma or serum samples to detect arboviral RNA.
  • Blood banks and collection centers could decide that deferrals are unnecessary if donors were tested and found negative using the Procleix ArboPlex Assay.
  • “With its 4-in-1 arbovirus test feature, the Grifols Procleix ArboPlex Assay has the ability to speed up and overall improve donor screening laboratory efficiency,” said Antonio Martínez, president of Grifols Diagnostic Business Unit.

QIAGEN announces partnership with Penn State University to advance microbiome sciences

Retrieved on: 
Thursday, January 25, 2024
Senior, Student, Chitin, NGS, Research, Microbiome, Arthropod, Animal, Health, RNA, Partnership, Joint, Spider, Faculty, Genetics, Pennsylvania State University, Skeleton, Real-time, Environment, Bacteria, Arbovirus, Human, Reproduction, Entomology, Dengue fever, State College, Pennsylvania, Laboratory, Zika virus, QIAGEN, MITES, Virus, Organization, Wolbachia, Plant, PCR, Automation, Ecology, Education, QGEN, Nested polymerase chain reaction, Fungus, Antibiotics

Germantown, Maryland, and State College, Pennsylvania, Jan. 25, 2024 (GLOBE NEWSWIRE) -- QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced a first-in-kind collaboration with Penn State University in the United States to create a shared research and education facility for the fast-developing microbiome sciences.

Key Points: 
  • Germantown, Maryland, and State College, Pennsylvania, Jan. 25, 2024 (GLOBE NEWSWIRE) -- QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced a first-in-kind collaboration with Penn State University in the United States to create a shared research and education facility for the fast-developing microbiome sciences.
  • In doing so, this new partnership will provide QIAGEN with a site to support the development of new products as a testing center.
  • This includes an internship program for graduate students from Penn State at QIAGEN laboratories at the European operational headquarters in Hilden, Germany, and helps them prepare for careers in the biotechnology industry.
  • “Additionally, it will foster relationships with the microbiome research community and enable us to better develop new products for microbiome research based on direct customer feedback.”
    Seth Bordenstein, Director of the One Health Microbiome Center, Professor of Biology and Entomology, and Huck Endowed Chair in the Microbiome Sciences, at Penn State said: “The ‘One Health’ vision shared by QIAGEN and Penn State University is critical for microbiome research.

Top Virologists to Meet in Monaco to Tackle Ongoing Pandemic Challenges and Emerging Viral Threats

Retrieved on: 
Wednesday, October 11, 2023
Partnership, Emergent virus, Doctor of Philosophy, University, Death, University of Maryland, Baltimore, CSM, MD, University of Maryland School of Medicine, Virology, Institute of Human Virology Nigeria, Viral disease, Emeritus, Yale School of Public Health, Prince, HIV, Entrepreneurship, Global Virus Network, AIDS, Virus, Friends, Maryland School, GVN, Challenge, Public health, Vaccine, Management, Arbovirus, EU

This coalition of the world’s leading medical virology researchers, who work together to prevent illness and death from viral disease, will hold high-level scientific sessions examining pandemic preparedness and current threats.

Key Points: 
  • This coalition of the world’s leading medical virology researchers, who work together to prevent illness and death from viral disease, will hold high-level scientific sessions examining pandemic preparedness and current threats.
  • A special GVN-CSM joint session will focus specifically on preparedness in European Union countries and will be attended by the High Patronage of H.S.H.
  • Prince Albert II of Monaco, among other dignitaries.
  • Lander Professor of Public Health, Yale School of Public Health as its next GVN President, effective November 1, 2023.

From fatal allergies to heart attacks and cholera – the devastating health effects of global warming in Africa

Retrieved on: 
Wednesday, September 6, 2023
People, Infection, Arbovirus, Food, Intergovernmental Panel on Climate Change, Vibrio, Gastroenteritis, Climate, Diarrhea, Stroke, City, Farmer, Dehydration, Rift Valley fever, Cardiovascular disease, Heat exhaustion, Splenic infarction, Livestock, Climate change, Chikungunya, Temperature, Risk, Heat stroke, Filariasis, Schistosomiasis, Human, Flood, Population, Time, Cholera, Water, Dengue fever, Pregnancy, Bacteria, Health, USGlobal Airways, Death, Environment, Food security, Pelvic floor dysfunction, Insecticide, Malaria, Agriculture, Animal husbandry, Vaccine, Tea

Wild fires create their own weather systems, generating fire storms with devastating effects.

Key Points: 
  • Wild fires create their own weather systems, generating fire storms with devastating effects.
  • Global warming will increase the number of days of shimmering heat, creating the ideal conditions for fire.
  • Global warming and El Niño combined suggest that the years ahead will result in increasing, devastating impacts.

Heat, air quality and health

    • High temperatures cause heat stroke, heat exhaustion, heart attacks, strokes and other cardiovascular disease.
    • People in informal settlements, and badly maintained and crowded buildings, are especially vulnerable to heat stress.

Less food, lower nutrition

    • In South Africa, drought recurrently affects subsistence agriculture, livestock and commercial crops.
    • The impact of drought on food and nutrition will be felt by the most vulnerable, including infants, small children and pregnant women and those who already live on or below the poverty line.
    • Crop failure and drought, combined with increased food costs associated with disruptions to global food resources, will affect every one of us.

Every drop counts

    • Humans require adequate hydration to survive, and the combination of increasing temperatures and water shortages heightens the risk of organ failure and death.
    • In addition, dependence on poor quality and contaminated water has an impact on household and personal hygiene, and intestinal infections.

Neglected diseases

    • Other viral and bacterial infectious diseases, especially prevalent in Africa, are also likely to increase with global warming.
    • Bundled together as “neglected diseases of poverty”, these include both parasitic and viral vector borne diseases such as Rift Valley fever, malaria, filariasis, schistosomiasis, dengue fever, chikungunya and influenza as well as arboviruses such as different influenza pathogens.

So where does this leave us?

    • When the Intergovernmental Panel on Climate Change was established in 1988, we had a choice to interrupt climate change and slow global warming.
    • This does not mean there is nothing we can do to halt the destruction of planetary life.

Noted Vaccine Researcher Thomas P. Monath Awarded Sabin’s Gold Medal; Cameroon Physician Sangwe Clovis Nchinjoh Receives Rising Star Award

Retrieved on: 
Tuesday, June 6, 2023
Vaccine, Arbovirus, Gold medal, United States Army Medical Research Institute of Infectious Diseases, Private sector, Sabin Vaccine Institute, Gold, USAMRIID, Vaccination, Virology, Public, Rising Star, Infection, Yellow fever, Smallpox, DRS, Viral, Research, CDC, Fever Dream, Division, Finan, United States Department of the Army, Korea Disease Control and Prevention Agency, Lassa fever, Health, Knowledge, Viral encephalitis, Science, R, System, MPH, Immunization, MD

WASHINGTON, June 06, 2023 (GLOBE NEWSWIRE) -- The Sabin Vaccine Institute today awarded the 30th Albert B. Sabin Gold Medal Award to Thomas P. Monath, MD, and its Rising Star Award to Sangwe Clovis Nchinjoh, MD, MPH, in a ceremony at Washington D.C.’s National Academy of Sciences building.

Key Points: 
  • WASHINGTON, June 06, 2023 (GLOBE NEWSWIRE) -- The Sabin Vaccine Institute today awarded the 30th Albert B. Sabin Gold Medal Award to Thomas P. Monath, MD, and its Rising Star Award to Sangwe Clovis Nchinjoh, MD, MPH, in a ceremony at Washington D.C.’s National Academy of Sciences building.
  • Past award recipients include leaders of vaccinology and vaccine advocacy such as Drs.
  • Sabin’s Rising Star is awarded to encourage and recognize the next generation of vaccine and immunization leaders.
  • “With his focus on strengthening immunization and health services among some of our most neglected communities, Dr. Nchinjoh exemplifies the spirit behind the Rising Star award,” says Finan.

Amadou Sall Honored with Prestigious Barka Award and Ten Diaspora Leaders Receive Luminaire Awards at African Diaspora Investment Symposium

Retrieved on: 
Monday, March 27, 2023
Dengue fever, Education, Face, Value chain, Senior, Bill & Melinda Gates Foundation, COVID-19, Luminary (podcast network), ADN, Ernst & Young, Side platform, Partner (business rank), Infection, Viral hemorrhagic fever, Government, McNeil Consumer Healthcare, Barka, Epidemic, Entrepreneurship, The Luminaire, City, Santa Clara University, Investment, Love, CFO, Pasteur Institute of Dakar, WHO, Health, Environment, World Health Organization, Film industry, Management, Arbovirus, Chikungunya, Ujamaa, Sanofi, Stripe

SILICON VALLEY, Calif., March 27, 2023 /PRNewswire-PRWeb/ -- The African Diaspora Network (ADN) demonstrated its dedication to leading diaspora philanthropy, investment, and innovation at the just concluded African Diaspora Investment Symposium (ADIS) with its diverse panel discussions, keynote addresses, and the presentation of its Barka and Luminarie awards to distinguished Africans and Diasporans.

Key Points: 
  • The African Diaspora Network demonstrated its dedication to leading diaspora philanthropy, investment, and innovation at the just concluded African Diaspora Investment Symposium (ADIS) with its diverse panel discussions, keynote addresses, and the presentation of its Barka and Luminarie awards to distinguished Africans and Diasporans.
  • This year, the Barka Award was presented on Thursday the 23rd of March 2023 to Dr. Amadou Alpha Sall for his leadership and contribution to healthcare development in Senegal and Africa.
  • "I can't think of a more deserving recipient of the Barka Award than my dear colleague and friend, Amadou Sall.
  • The Barka and Luminaires awardees were honored during a private awards dinner held on Thursday, March 23, 2023 at Santa Clara University.

Government of Canada invests in the next generation of scientists and researchers

Retrieved on: 
Monday, November 28, 2022
Government of Canada, Social Sciences and Humanities Research Council, Natural science, Canadian Institutes of Health Research, Engineering, University, Vanier Canada Graduate Scholarships, Gene, Parliamentary system, Universite des Sciences Appliquée et Management, Student, Knowledge, Social, Ontario Institute for Cancer Research, Humanities, Education, STEM, Dalhousie University, Government, Ecology, Disability, Public, Research, The Honourable, Arbovirus, Social science, Human, Black Canadians, Investment, Harkness Fellowship, Medicine, Forestry, Pharmaceutical industry, Health, Vanier, Science

OTTAWA, ON, Nov. 28, 2022 /CNW/ - The Government of Canada values Canada's scientific community and proudly supports scientists and researchers in building a stronger, healthier and more equitable future for Canada.

Key Points: 
  • OTTAWA, ON, Nov. 28, 2022 /CNW/ - The Government of Canada values Canada's scientific community and proudly supports scientists and researchers in building a stronger, healthier and more equitable future for Canada.
  • These scholars are the next generation of top-tier doctoral students and postdoctoral researchers in health, natural sciences and engineering, and social sciences and humanities.
  • "The Government of Canada continues to make record investments in science and research because we know it's key to creating a more equitable future for all.
  • Since 2016, the Government of Canada has invested more than $14 billion in science and research across the country.

Tevogen Bio CEO Dr. Ryan Saadi Appointed to Yale School of Public Health Leadership Council

Retrieved on: 
Wednesday, October 27, 2021
Biotechnology, General Health, Pharmaceutical, Health, Yale School of Public Health, Degenerative disease, Science, Cervical cancer, Infection, Cancer, ExxonMobil, Efficiency, NSCLC, Technology, Arbovirus, Goal, Public–private partnership, National academy, National, Thomas Jefferson University, Bio, Health equity, Yale school, Patient, Hepatitis B, Hepatitis, FDA, Global Medical Aid, T cell, Interfaith Leadership Council of Metropolitan Detroit, Severe acute respiratory syndrome coronavirus 2, Medicine, Anna, Immunity, Public health, Climate change, Company, Council, Fever Dream, COVID-19, CTLS, Epidemic, Anti-racism, Conditional sentence, Health, HIV/AIDS, The Leadership Council, Therapy, School, Education, Management, Pharmaceutical industry, Vaccine, Tevogen Bio, Yale School of Public Health, TEVOGEN BIO, YALE SCHOOL OF PUBLIC HEALTH

to the Yale School of Public Health (YSPH) Leadership Council .

Key Points: 
  • to the Yale School of Public Health (YSPH) Leadership Council .
  • The Leadership Council is committed to advancing YSPH as a global leader in public health.
  • Established in 1915 as one of the first schools of public health in the United States, the Yale School of Public Health (YSPH) is consistently ranked among the best schools of public health in the country.
  • A CEPH-certified school of public health, YSPH is at the forefront of advancing education, science and public health for the 21st century.

2020 Western Equine Encephalitis - Pipeline Review, H1 - ResearchAndMarkets.com

Retrieved on: 
Thursday, July 30, 2020
Infectious diseases, Pharmaceutical, Health, Medical specialties, Viral encephalitis, Medicine, Clinical medicine, Viruses, Neglected tropical diseases, Tropical diseases, RTT, Equine encephalitis, Western equine encephalitis virus, Arbovirus, Encephalitis

The publisher's latest Pharmaceutical and Healthcare disease pipeline guide Western Equine Encephalitis - Pipeline Review, H1 2020, provides an overview of the Western Equine Encephalitis (Infectious Disease) pipeline landscape.

Key Points: 
  • The publisher's latest Pharmaceutical and Healthcare disease pipeline guide Western Equine Encephalitis - Pipeline Review, H1 2020, provides an overview of the Western Equine Encephalitis (Infectious Disease) pipeline landscape.
  • Western equine encephalitis is caused by the western equine encephalitis virus, an arbovirus.
  • The publisher's Pharmaceutical and Healthcare latest pipeline guide Western Equine Encephalitis - Pipeline Review, H1 2020, provides comprehensive information on the therapeutics under development for Western Equine Encephalitis (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type.
  • The Western Equine Encephalitis (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Western Equine Encephalitis and features dormant and discontinued projects.

Insights into the Arbovirus Testing Global Market to 2025 - North America Dominates the Industry - ResearchAndMarkets.com

Retrieved on: 
Friday, July 24, 2020
Infectious diseases, Pharmaceutical, Health, Natural sciences, Branches of biology, Laboratory techniques, Molecular biology, Biology, Biotechnology, Amplifiers, Polymerase chain reaction, Arbovirus, Reverse transcription polymerase chain reaction, Forecast period

RT-PCR based tests segement is expected to dominate the Arbovirus Testing Market over the forecast period attributing to its advantages.

Key Points: 
  • RT-PCR based tests segement is expected to dominate the Arbovirus Testing Market over the forecast period attributing to its advantages.
  • Hence, all these factors together suggests that RT-PCR based tests dominates the Arboviral Testing market during the forecast period.
  • North America Dominates the Market and the Same is Expected Over the Forecast Period.
  • Thus, North America dominates the Arboviral Testing market during the forecast period.